Capital Investment Advisory Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $203K | Buy |
|
|||||
|
2025
Q1 | $105K | Hold |
|
|||||
|
2024
Q4 | $117K | Hold |
|
|||||
|
2024
Q3 | $128K | Sell |
|
|||||
|
2024
Q2 | $244K | Sell |
|
|||||
|
2024
Q1 | $668K | Sell |
|
|||||
|
2023
Q4 | $823K | Sell |
|
|||||
|
2023
Q3 | $1.5M | Buy |
|
|||||
|
2023
Q2 | $1.67M | Sell |
|
|||||
|
2023
Q1 | $1.63M | Sell |
|
|||||
|
2022
Q4 | $1.93M | Sell |
|
|||||
|
2022
Q3 | $1.86M | Sell |
|
|||||
|
2022
Q2 | $2.14M | Buy |
|
|||||
|
2022
Q1 | $1.01M | Buy |
|
|||||
|
2021
Q4 | $947K | Buy |
|
|||||
|
2021
Q3 | $986K | Buy |
|
|||||
|
2021
Q2 | $709K | Buy |
|
|||||
|
2021
Q1 | $375K | Buy |
|
|||||
|
2020
Q4 | $246K | Hold |
|
|||||
|
2020
Q3 | $195K | Buy |
|
|||||
|
2020
Q2 | $190K | Hold |
|
|||||
|
2020
Q1 | $132K | Buy |
|
|||||
|
2019
Q4 | $158K | Buy |
|
|||||
|
2019
Q3 | $38K | Hold |
|
|||||
|
2019
Q2 | $43K | Hold |
|
|||||
|
2019
Q1 | $45K | Sell |
|
|||||
|
2018
Q4 | $70K | Sell |
|
|||||
|
2018
Q3 | $214K | Sell |
|
|||||
|
2018
Q2 | $247K | Buy |
|
|||||
|
2018
Q1 | $211K | Buy |
|